期刊文献+

健康相关生命质量评价在社区乙型肝炎患者中的应用 被引量:5

Clinical value of health-related quality of life evaluation in community patients with hepatitis B
原文传递
导出
摘要 慢性乙型病毒性肝炎是危害全球人民生命健康的重大传染性疾病。健康相关生命质量(HRQoL)已成为评价慢性乙型肝炎患者治疗和预后的一个良好指标。国外许多研究结果表明慢性乙型肝炎患者的HRQoL受到不同程度的影响。病情的严重程度、临床症状和自我效能感不足等是影响患者生活质量的重要因素。对社区慢性乙型肝炎患者采取抗病毒治疗、适当的物理治疗或心理干预,都可以显著提高其HRQoL。甚至肝移植1年后的患者,HRQoL亦明显好转。这为乙型肝炎患者的抗病毒治疗和肝移植技术从心理学层面提供了有效证据。目前国内对慢性乙型肝炎患者的HRQoL研究尚处于空白阶段,现概述国内外近年广泛使用的HRQoL的测量工具,并对社区乙型肝炎患者的健康相关生命质量研究进展作一综述,以及对今后的相关研究进行讨论和展望。 Chronic hepatitis B (CHB) is a major infectious disease which threatens people's health around the world. Health-related quality of life (HRQoL) has become an important index for evaluating the treatment and prognosis of patients with CHB. Many studies abroad have shown that the HRQoL of patients with CHB is influenced by various factors. Disease severity, clinical symptoms, and low self-efficacy are important influencing factors for patients' quality of life. Anti-viral therapy, proper physical therapy, or psychological intervention can significantly improve the HRQoL of community CHB patients, and HRQoL is even significantly improved in patients undergoing liver transplantation one year ago. These studies provide valid evidence for antiviral therapy for hepatitis B patients and liver transplantation techniques from the psychological level. At present, there still lacks studies on HRQoL of CHB patients in China. This article summarizes the measurement tools for HRQoL widely used in recent years in China and foreign countries, reviews the research advances in HRQoL in community patients with CHB, and discusses the perspectives for future studies.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2017年第4期313-316,共4页 Chinese Journal of Hepatology
基金 国家十二五科学技术重大专项(2013ZX10004904,2014ZX10004008),浙江省卫生科技计划项目(2016KYA079)
关键词 肝炎 乙型 慢性 健康相关生命质量 心理干预 Hepatitis B, chronic Health-related quality of life Psychological intervention
  • 相关文献

参考文献5

二级参考文献34

  • 1Teresa Antonia Santantonio,Massimo Fasano.Chronic hepatitis B: Advances in treatment[J].World Journal of Hepatology,2014,6(5):284-292. 被引量:12
  • 2Yu-YuanLi,Yu-QiangNie,Wei-HongSha,ZhengZeng,Fu-YingYang,LiPing,LinJia.Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China[J].World Journal of Gastroenterology,2004,10(16):2397-2401. 被引量:23
  • 3El-Scrag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma[J]. Gastroenterology, 2012, 142(6): 1264-1273.
  • 4Kim SS, Hwang JC, Lira SG, et al. Effect of virological response to enteeavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis[J]. Am J Gastroenterol, 2014, 109(8): 1223-1233.
  • 5Ringelhan M, O'Connor T, Protzer U, et al. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets[J]. J Pathol, 2015, 235(2): 355-367.
  • 6Li Y, Zhang Z, Shi J, et al. Risk factors for naturally-occurring early- onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China[J]. lnt J Clin Exp Med, 2015, 8(1): 1205-1212.
  • 7Lin CW, Lin CC, Mo LR, et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B viresrelated cirrhosis[J]. J Hepatol, 2013, 58(4): 730-735.
  • 8Nault JC. Pathogenesis of hepatocellular carcinoma according to aetiology[J]. Best Pratt Res Clin Gastroenterol, 2014, 28(5): 937- 947.
  • 9Mercer KE, Hermings L, Ronis MJ. Alcohol consumption, Wnt/beta- catenin signaling, and hepatoeareinogenesis[J]. Adv Exp Med Biol, 2015, 815: 185-195.
  • 10Thiele M, Gluud LL, Dalai EK, et al. Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis[J]. BMJ Open, 2013, 3(8).

共引文献1357

同被引文献59

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部